Related Experiment Videos
Malignant hemangioendothelioma of bone
The Journal of Bone and Joint Surgery. American Volume
|January 1, 1975
Summary
Malignant hemangioendothelioma of bone is a rare cancer affecting any bone in all age groups. Prognosis is poor, but radiation therapy offers a chance for long-term survival in some cases.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Malignant hemangioendothelioma of bone is a rare vascular tumor.
- It can affect any bone and all age groups.
- Skeletal metastases may precede pulmonary detection.
Purpose of the Study:
- To describe the clinical and histopathological features of malignant hemangioendothelioma of bone.
- To evaluate the prognosis and treatment outcomes.
Main Methods:
- Retrospective case series analysis.
- Review of clinical and histopathological data from seven patients.
- Analysis of treatment responses, particularly radiation therapy.
Main Results:
- Seven cases of malignant hemangioendothelioma of bone were analyzed.
- The neoplasm affects all age groups and can occur in any bone.
- Prognosis is generally poor, with a 5-year survival rate of 2/6 in this series.
- One patient achieved long-term survival (>12 years) after radiation therapy for widespread frontal skull bone destruction.
- A case arising in chronic osteomyelitic bone was also described.
Conclusions:
- Malignant hemangioendothelioma of bone is a rare and aggressive tumor with a poor prognosis.
- Radiation therapy can be effective in controlling localized disease and achieving long-term survival in select cases.
- Further research is needed to understand the pathogenesis and improve treatment strategies.